A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
for Follicular Lymphoma
Drug: Mosunetuzumab
9 locations incl. Washington D.C.
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT05389293·Phase 2·Recruiting